Annals of Tropical Medicine and Public Health
Home About us Ahead Of Print Instructions Submission Subscribe Advertise Contact e-Alerts Editorial Board Login 
Users Online:336
  Print this page  Email this page Small font sizeDefault font sizeIncrease font size
 


 
Table of Contents   
CASE REPORT  
Year : 2011  |  Volume : 4  |  Issue : 2  |  Page : 126-127
Isoniazid-induced psychosis in a patient on DOTS therapy


1 Department of Medicine, ASCOMS and Hospitals, Jammu, J and K, India
2 Department of Chest Medicine and Tuberculosis, ASCOMS and Hospitals, Jammu, J and K, India

Click here for correspondence address and email

Date of Web Publication8-Oct-2011
 

   Abstract 

Acute psychosis induced by INH, especially when given as part of the DOTS regimen, has a variable presentation, and should always be kept in mind in the differential diagnosis. The diagnosis becomes especially challenging when the patient has tubercular meningitis or some other neurological disease. Here we present a case report of a patient who after 2 days of INH therapy under the DOTS regimen developed acute psychosis that resolved only after discontinuation of the drug.

Keywords: Antitubercular therapy, DOTS, isonicotinic acid hydrazide

How to cite this article:
Masood I, Bhat S, Beigh A, Gupta V. Isoniazid-induced psychosis in a patient on DOTS therapy. Ann Trop Med Public Health 2011;4:126-7

How to cite this URL:
Masood I, Bhat S, Beigh A, Gupta V. Isoniazid-induced psychosis in a patient on DOTS therapy. Ann Trop Med Public Health [serial online] 2011 [cited 2018 Aug 15];4:126-7. Available from: http://www.atmph.org/text.asp?2011/4/2/126/85769

   Introduction Top


Isonicotinic acid hydrazide (INH), which was introduced by Robitzek more than half a century ago in 1952, is still one of the primary drugs used in the treatment of Mycobacterium tuberculosis infection. It is both safe and effictive. The common side effects of INH are peripheral neuropathy, hepatitis, and rash. Rarely, psychosis, convulsions, and even death have been reported on conventional doses of this drug. [1],[2] No definite data is available on potential toxicity, especially neurotoxicity, when the drug is used in high doses of 15 mg/kg under DOTS, i.e., thrice weekly. [3]


   Case Report Top


An 84-year-old Asian male, a farmer by occupation and a smoker, was admitted with complaints of right-sided pleuritic chest pain of 1 month's duration; productive cough, hemoptysis, and breathlessness of 1 week's duration; and a history of low-grade feverfor1 month. No history of orthopnea or paroxysmal nocturnal dyspnea (PND) was present. There was no significant past history. On examination, the patient was hemodynamically stable. In the chest, the signs of a right-sided pleural effusion were present. Investigations revealed a normal hemogram, ESR 80 mm for the first hour, random blood glucose 98 mg/dl, blood urea 28 mg/dl, serum creatinine 1.0 mg/dl, serum total protein 6.5 g/dl, serum albumin 4.6 g/dl, total bilirubin 0.8 mg/dl, SGOT(Aspartate Aminotransferase) 28 U/l, SGPT(Alanine Aminotransferase) 30 U/l, and alkaline phosphatase 60 U/l. X-ray chest revealed right-sided hydropneumothorax. CECT(Contrast Enhanced Computer Tomography) chest confirmed the presence of a right-sided hydropneumothorax and also revealed underlying collapse consolidation of the right lower lobe and middle lobe. The pleural fluid was grossly thick and yellow, with a total cell count of 5000/ mm 3 (99% lymphocytes and 1% neutrophils). Gram's stain and acid-fast bacilli (AFB) stain of the pleural fluid was negative. Pleural fluid biochemistry showed total protein 5.2 g/dl, glucose 102 mg/dl, LDH (Lactate Dehydrogenase) 28080 U/l, and ADA (Adenosine deaminase) 322.14 IU/l. Sputum smear was negative for AFB or fungi. Ultrasound abdomen showed no significant abnormality. The patient was put on intercostal tube drainage and intravenous antibiotics initially for 3 days and later, after pleural fluid reports were received, on antitubercular therapy (ATT) as per the DOTS category-I regimen. While on ATT, on the 5 th day after admission, the patient developed confusion, incoherence, occasional violent behavior, irrelevant talking, and incongruent acts. He was reevaluated but there were no signs of any focal neurological deficit except the higher function alterations on examination. CECT head was done but revealed no abnormality. Arterial blood gas analysis, repeat hemogram, kidney function tests, and liver function tests were all repeated but were within normal limits. On receiving the second dose of ATT, his confusion and incoherence increased and the decision to stop ATT was taken. Five days after stopping the drugs he had completely improved. ATT was then restarted, with levofloxacin instead of INH. The patient maintained his normal sensorium on this new regimen. The chest tube was removed on the 15 th day and he was discharged on ATT (without INH). On follow-up the patient was doing well.


   Discussion Top


Adverse drug reaction and intolerance is well known for most medications, especially when used in high doses. ATT is no exception. DOTS therapy has definitely proven to be effective in terms of cure rates [4] but owing to the high doses of the drugs, tolerance and compliance is a concern.

INH is one of the primary drugs of the ATT regimen because of its low cost and high safety and potency. However, it is known to have side effects such as peripheral neuropathy, hepatitis, psychosis, etc. [1],[2] In 1953, the committee of therapy of American Trudeau society estimated that toxic reactions due to INH occurred in 5% of patients, with 1% having serious reactions. [5]

Our extensive search of the literature did not reveal a similar case of high-dose [3] INH (used in DOTS regimen) giving rise to psychosis, though there are many case reports of INH-induced psychosis in patients on non-DOTS regimen. [1] The mechanism for the INH-induced psychosis or other related disorders is not clearly understood. [6] This drug is known to interfere with various metabolic pathways essential for neuronal functioning. INH causes vitamin B 6 deficiency by increasing its excretion. INH also inhibits brain pyridoxal-5-phosphate activity, which leads to decreased brain levels of GABA and some other synaptic neurotransmitters. [7] Susceptibility is increased by advanced age, alcohol intake, diabetes, family history, malnutrition, hepatic insufficiency, etc.

There is great variability in the clinical features of INH-induced psychosis in the reported cases. Jackson, in 1957, reported five cases of INH-induced psychosis that presented with argumentive behavior, mental depression, euphoria, grandiose ideas, and complex delusions; none of these patients had any previous history of mental illness. [8] Agarwala, in 1974, reported symptoms of restlessness, irritability, emotional instability, agitation, apprehension, and fluctuation in behavior after isoniazid therapy [9] (this was similar to the features seen in our patient). Bedi, in 1994, reported a case of INH-induced psychosis in a 74-year old who developed restlessness, irritability, aimless activity, and incongruous actions 10 days after starting isoniazid therapy. [10] In 1996, Tiwari reported a case of INH-induced psychosis presenting with disturbed sleep, restlessness, and abnormal behavior [11] (similar to the present case). The duration of psychotic symptoms in these case reports varied widely, i.e., 7-45 days, [8] 7 days, [7] 10 days, [8] and 120 days. [9]


   Conclusion Top


Acute psychosis induced by INH, especially when given in the DOTS regimen, has a variable presentation. The possibility should always be considered in the differential diagnosis. Diagnosis is especially challenging when the patient has tubercular meningitis or some other preexisting neurological disease. The administration of pyridoxine, which has been advocated for prevention and treatment of INH-induced neurological manifestations, [12] failed to reverse the psychosis in our patient; only discontinuation of the culprit drug proved to be effective.

 
   References Top

1.Dixon GJ, Robert GB, Tyrrell WF. The relationship of neuropathy to the treatment of tuberculosis with isoniazid. Scot Med J 1956;1:350-4.  Back to cited text no. 1
    
2.Janssen G, Boke W. [The increase of optic nerve participation in meningeal tuberculosis during INH and streptomycin therapy]. Klin Wochenschr 1955;33:477-9.  Back to cited text no. 2
[PUBMED]    
3.Raviglione MC, O'Brien RJ. Tuberculosis. In: Fauci, Braunwald Kasper, Hauser, Longo, Jameson, Loscalzo, editors. Harrison's Principle of Internal Medicine. 17 th ed. vol 1. Philadelphia: Mc Graw-Hill; 2008. p. 1006-20.  Back to cited text no. 3
    
4.WHO (2006), Global Tuberculosis Control, Surveillance, Planning and Financing, WHO Report 2006.  Back to cited text no. 4
    
5.TOXICITY of isoniazid; a report of the Committee on Therapy of the American Trudeau Society. Am Rev Tuberc 1953;68:302-5.  Back to cited text no. 5
    
6.Holtz P, Palm D. Pharmacological aspects of vitamin B 6 . Pharmacol Rev 1964;16:113-78.  Back to cited text no. 6
[PUBMED]  [FULLTEXT]  
7.Girlin DJ. Adverse effects of antituberculosis drugs. Bull Int Union Tuberc 1984;53:152.  Back to cited text no. 7
    
8.Jackson SL. Psychosis due to isoniazid. Br Med J 1957;28:743-6.  Back to cited text no. 8
    
9.Agarwal MC, Kansal HM, Gupta RK, Gupta DK, Kumar S. Toxic psychosis due to isoniazid. Indian J Tuberc 1994;3:119-20.  Back to cited text no. 9
    
10.Bedi RS. Isoniazid induced pyrexia and psychosis in a single individual. Indian J Tuberc 1994;41:269-70.  Back to cited text no. 10
    
11.Tiwari VK, Verma SM. Homicide by a tuberculous prisoner possibly having drug induced acute delusional psychosis. Indian J Tuberc 1997;44:95-6.  Back to cited text no. 11
    
12.Aloa AO, Yolles JC. Isoniazid-induced psychosis. Ann Pharmacother 1998;9:889-91.  Back to cited text no. 12
    

Top
Correspondence Address:
Imran Masood
E-21, E block, PG Hostel, ASCOMS and Hospital, Sidhra, Jammu - 180 017, J and K
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1755-6783.85769

Rights and Permissions




 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *


    Abstract
   Introduction
   Case Report
   Discussion
   Conclusion
    References

 Article Access Statistics
    Viewed5536    
    Printed138    
    Emailed2    
    PDF Downloaded20    
    Comments [Add]    

Recommend this journal